KCT0009171Not yet recruitingUnknown
Effect Site Concentration of Remimazolam during general anesthesia by different age groups in Patients Undergoing Target-controlled infusion for Minimally Invasive Surgery: a retrospective study.
The Catholic University of Korea, Yeouido St. Mary's Hospital0 sites90 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Enrollment
- 90
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20(Year) to 80(Year) (—)
- Sex
- All
Inclusion Criteria
- •Patients who received targeted concentration-controlled infusion of remimazolam using the Schuttler model for elective surgery at Yeouido St. Mary's Hospital from September 2022 to July 31, 2023, patients who received
Exclusion Criteria
- •Patients administered other inhaled anesthetics or sedative hypnotics during anesthesia
- •Patients whose dosage of remimazolam or remifentanil is unclear
- •Patients with missing hemodynamic data
Investigators
Similar Trials
Recruiting
Not Applicable
Observational study of the effects of remimazolam on MEP in spinal surgerySpine surgeryJPRN-UMIN000042367Hamamatsu University School of Medicine150
Not yet recruiting
Unknown
Evaluation of the Effect of Remimazolam on Intraoperative Motor Evoked Potential Monitoring - Comparison with PropofolJPRN-UMIN000049191niversity of Occupational and Environmental Health, Japan60
Not yet recruiting
Not Applicable
Investigation of the Effect of Remimazolam on Circulatory Management in Transurethral Resection of Bladder Tumor with 5-Aminolevulinic AcidMuscle layer non-invasive bladder cancerJPRN-UMIN000052910Chiba University200
Recruiting
Not Applicable
Elucidation of pharmacokinetics at the end of remimazolam administratoiJPRN-UMIN000041438Department of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine40
Recruiting
Unknown
Pharmacodynamic interaction between remimazolam and remifentanil during anesthesia induction - randomized trialJPRN-jRCTs031230301Masui Kennichi40